IAM · Insider trading · 13F holders · Congress trades
Iambic Therapeutics, Inc. (IAM)
Who is buying and selling IAM: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $11.5M
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
IAM at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 IAM insider filed 1 open-market purchase worth $11.5M on SEC Form 4.
- No 13F filer reports IAM among its 50 largest positions.
- No member of Congress has disclosed a trade in IAM.
- IAM last closed at $14.28 on Oct 29, 2026.
IAM insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 IAM insider filed 1 open-market purchase worth $11.5M on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Rachlin Evan Lockwood | Director | Buy | 718,750 | $16.00 | $11.5M | SEC |
Who owns IAM? Hedge funds and superinvestors
No 13F filer reports IAM among its 50 largest positions.
IAM stock trades by members of Congress
No member of Congress has disclosed a trade in IAM.
Analysis mentioning IAM
Posts from the blog that cover Iambic Therapeutics, Inc., newest first.
IAM questions and answers
Are insiders buying IAM stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 IAM insider filed 1 open-market purchase worth $11.5M on SEC Form 4.
Which hedge funds own IAM?
No 13F filer reports IAM among its 50 largest positions.
Has Congress traded IAM?
No member of Congress has disclosed a trade in IAM.
Cite or share this
Free to use with a link back. The data updates every filing day.